UY33098A - Composiciones farmaceuticas que contienen 5-amino-4-hidroxi-pentoil amidas como inhibidores de vih - Google Patents

Composiciones farmaceuticas que contienen 5-amino-4-hidroxi-pentoil amidas como inhibidores de vih

Info

Publication number
UY33098A
UY33098A UY0001033098A UY33098A UY33098A UY 33098 A UY33098 A UY 33098A UY 0001033098 A UY0001033098 A UY 0001033098A UY 33098 A UY33098 A UY 33098A UY 33098 A UY33098 A UY 33098A
Authority
UY
Uruguay
Prior art keywords
pharmaceutical compositions
compositions containing
pentoil
amidas
hidroxi
Prior art date
Application number
UY0001033098A
Other languages
English (en)
Inventor
Johanes Wilhelmus John F Thuring
Genadiy Kalayanov
Kesteleyn Bart Rudolf Romanie
Kevin Parkes
Samuelsson Bengt Bertil
Schepens Wim Bert Griet
Wallberg Hans Kristian
Wegner Joerg Kurt
Original Assignee
Medivir Ab
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab, Tibotec Pharm Ltd filed Critical Medivir Ab
Publication of UY33098A publication Critical patent/UY33098A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Abstract

Inhibidores del VIH de la fórmula (l) y sus sales de adicción farmacéuticamente aceptables y los solvatos de los mismos en donde los sustituyentes son tales como se especifican en la Memoria Descriptiva y en las reivindicaciones; composiciones farmacéuticas que contienen dichos compuestos como principio activo y procesos para preparar dichos compuestos.
UY0001033098A 2009-12-11 2010-12-10 Composiciones farmaceuticas que contienen 5-amino-4-hidroxi-pentoil amidas como inhibidores de vih UY33098A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09178979 2009-12-11
EP10162370 2010-05-10

Publications (1)

Publication Number Publication Date
UY33098A true UY33098A (es) 2011-06-30

Family

ID=43534084

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033098A UY33098A (es) 2009-12-11 2010-12-10 Composiciones farmaceuticas que contienen 5-amino-4-hidroxi-pentoil amidas como inhibidores de vih

Country Status (24)

Country Link
US (1) US8592429B2 (es)
EP (1) EP2509950B1 (es)
JP (1) JP5797662B2 (es)
KR (1) KR101771698B1 (es)
CN (1) CN102770413B (es)
AP (1) AP3217A (es)
AR (1) AR079354A1 (es)
AU (1) AU2010329867B2 (es)
BR (1) BR112012013493B1 (es)
CA (1) CA2783929C (es)
DK (1) DK2509950T3 (es)
EA (1) EA020758B1 (es)
ES (1) ES2536774T3 (es)
HK (1) HK1177454A1 (es)
IL (1) IL219272A (es)
JO (1) JO3090B1 (es)
MX (1) MX2012006613A (es)
NZ (1) NZ599916A (es)
PL (1) PL2509950T3 (es)
PT (1) PT2509950E (es)
SG (1) SG181609A1 (es)
TW (1) TWI485149B (es)
UY (1) UY33098A (es)
WO (1) WO2011070131A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7111733B2 (ja) 2017-03-16 2022-08-02 江蘇恒瑞医薬股▲ふん▼有限公司 ヘテロアリール［４，３－ｃ］ピリミジン－５－アミン誘導体、その製造方法、およびその医薬の使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
EP0534511A1 (en) * 1991-08-16 1993-03-31 Merck & Co. Inc. HIV protease inhibitors useful for the treatment of aids
CN1089269A (zh) * 1993-01-04 1994-07-13 希巴-盖吉股份公司 新颖的作为治疗剂的5-氨基-4-羟基己酸衍生物
US5733882A (en) * 1994-01-17 1998-03-31 Smithkline Beecham Corporation Retroviral protease inhibitors
ATE220661T1 (de) * 1994-10-19 2002-08-15 Novartis Erfind Verwalt Gmbh Antivirale ether von aspartat-protease-substrat- isosteren
ES2275866T3 (es) * 2001-02-14 2007-06-16 Tibotec Pharmaceuticals Ltd. 2-(aminosustituido)-benzotiazol-sulfonamidas de amplio esprecto inhibidoras de la proteasa de vih.
TWI286476B (en) * 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
US7834043B2 (en) * 2003-12-11 2010-11-16 Abbott Laboratories HIV protease inhibiting compounds
CN101115713A (zh) * 2005-02-10 2008-01-30 美迪维尔公司 人类免疫缺陷性病毒蛋白酶抑制剂
ATE429417T1 (de) * 2005-02-10 2009-05-15 Medivir Ab Hiv-protease-inhibitoren
WO2007048557A1 (en) * 2005-10-25 2007-05-03 Medivir Ab Protease inhibitors
JO2841B1 (en) * 2006-06-23 2014-09-15 تيبوتيك فارماسيوتيكالز ليمتد 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV)
EP2069303B1 (en) * 2006-07-21 2016-03-30 Gilead Sciences, Inc. Antiviral protease inhibitors

Also Published As

Publication number Publication date
AU2010329867A1 (en) 2012-05-24
JO3090B1 (ar) 2017-03-15
CA2783929A1 (en) 2011-06-16
JP5797662B2 (ja) 2015-10-21
ES2536774T3 (es) 2015-05-28
TWI485149B (zh) 2015-05-21
AP2012006228A0 (en) 2012-04-30
PT2509950E (pt) 2015-06-08
PL2509950T3 (pl) 2015-10-30
EA201290487A1 (ru) 2012-11-30
AR079354A1 (es) 2012-01-18
CN102770413B (zh) 2015-08-26
WO2011070131A1 (en) 2011-06-16
SG181609A1 (en) 2012-07-30
HK1177454A1 (en) 2013-08-23
BR112012013493A2 (pt) 2016-05-31
CN102770413A (zh) 2012-11-07
MX2012006613A (es) 2012-07-10
JP2013513576A (ja) 2013-04-22
AU2010329867B2 (en) 2016-01-28
NZ599916A (en) 2013-10-25
KR101771698B1 (ko) 2017-08-25
BR112012013493B1 (pt) 2020-12-08
IL219272A (en) 2014-09-30
IL219272A0 (en) 2012-06-28
DK2509950T3 (en) 2015-05-18
US20120295920A1 (en) 2012-11-22
CA2783929C (en) 2020-04-07
EP2509950A1 (en) 2012-10-17
EP2509950B1 (en) 2015-02-25
KR20120107104A (ko) 2012-09-28
EA020758B1 (ru) 2015-01-30
US8592429B2 (en) 2013-11-26
BR112012013493A8 (pt) 2017-12-26
TW201130823A (en) 2011-09-16
AP3217A (en) 2015-04-30

Similar Documents

Publication Publication Date Title
DOP2019000030A (es) Inhibidores de cdk2/4/6
CR20140399A (es) Pirrolidina-2-carboxamidas sustituidas
NI201800132A (es) Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
UY33536A (es) INHIBIDORES BICÍCLICOS DE ACETIL-CoA-CARBOXILASA Y USOS DE LOS MISMOS
ECSP14013215A (es) Compuestos novedosos
CO6400220A2 (es) Derivados de sulfonamida
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
DOP2013000221A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO[2,3-d]PIRIMIDINA TROPOMIOSINA
CU20140089A7 (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CU20160007A7 (es) Derivados de 2((( oxadiazol/triazol/tetrazol/isoxazol) metil) fenil)-1-(heterociclil)-ona como inhibidores activos de autotaxina
CR11641A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211
UY33606A (es) DERIVADOS DE PIRAZINA COMO BLOQUEADORES DE ENaC
UY33775A (es) Inhibidores macrocíclicos de virus flaviviridae, composiciones farmacéuticas que los comprenden y sus usos
UY33078A (es) Derivados de imidazoquinolina
ECSP088666A (es) Derivados de las benzamidas y heteroarenos
UY32315A (es) Compuestos de piperidina y usos de los mismo-596
UY31860A (es) Piridinas de tiazolo como inhibidoras de la adn girasa
UY32387A (es) Ciclopentanodionas herbicidamente activas, derivados, procesos para su preparación, composiciones que las comprenden y usos de las mismas
ECSP089019A (es) Inhibidores de sulfonamida tricíclicos, fusionados del gama secretasa
UY31141A1 (es) Compuestos de piperidina y sus usos
CO6382176A2 (es) Derivados de urea heterociclicos y metodos de uso de los mismos-332
CU20110233A7 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas
UY32674A (es) Derivados heterociclicos de la urea y sus metodos de empleo
UY32856A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
UY32694A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20210707